Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR)
| CAPS Rating |
|
|---|---|
| Open | $13.21 |
| Previous Close | $13.29 |
| Daily Range | $13.12 - $13.62 |
| 52-Week Range | $6.81 - $17.95 |
| Market Cap | $631.01M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 346,152 |
| Average Daily Volume | 0 |
OPTR
VS S&P 500 (SPY)
How do you think OPTR will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OPTR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OPTR News and Commentary
- The Fastest Growers in Pharma – The Motley Fool
- Cubicin Drives Cubist Pharma - Analyst Blog – NASDAQ
- Earnings Preview: Cubist Pharma - Analyst Blog – NASDAQ
- Optimer Buoyant on Difficid Sales - Analyst Blog – NASDAQ
- Cubist's Preliminary Sales Impress - Analyst Blog – NASDAQ
- Pipeline Progress at Cubist Pharma - Analyst Blog – NASDAQ
- Cubist Pharma Buys Adolor - Analyst Blog – NASDAQ
- Optimer Moved Down to Neutral - Analyst Blog – NASDAQ
- Health-Care News You Can't Afford to Miss – The Motley Fool
- Don't Get Too Worked Up Over ViroPharma's Latest Numbers – The Motley Fool
- Optimer Pharmaceuticals Shares Dropped: What You Need to Know – The Motley Fool
- Is ViroPharma's Growth for Real? – The Motley Fool
- Is Optimer Pharmaceuticals the Perfect Stock? – The Motley Fool
- Optimer Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- Friday Morning Watchlist – Blog at The Motley Fool
- This Week in Biotech – The Motley Fool
- Risk and Reward: Hedge Funds Love These Stocks With Rising Volatility – The Motley Fool
- Risk and Reward: Hedge Funds Love These Stocks With Rising Volatility – NASDAQ
- 5 of Last Week's Biggest Winners – The Motley Fool
- The 20 Fastest Growers in Pharma – The Motley Fool
RSS Headlines
Fool UK
